Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 2

Interventions

Temozolomide 43Magnetic Resonance Spectroscopy 39Specimen Handling 28Radiotherapy 19Radiation 16Bevacizumab 13Radiosurgery 12Nivolumab 12Biopsy 12X-Rays 10Cyclophosphamide 9Carboplatin 9Nuclear Medicine Department, Hospital 7Lomustine 7Irinotecan 7pembrolizumab 6Ipilimumab 6Cisplatin 6AZD 6244 6Vincristine 5Topotecan 5Phantoms, Imaging 5Etoposide 5CTLA-4 Antigen 5ulixertinib 4trametinib 4olaparib 4erdafitinib 4dinutuximab 4binimetinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
saponin QA-21V1 × CNS × 30 days × Clear all
NCT06057948 2026-06-05

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
94 enrolled
CNS

Neuroblastoma

NCT04936529 2026-05-07

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
286 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡